ALT 0.00% 0.1¢ analytica limited

Question for webinar, page-25

  1. 134 Posts.
    lightbulb Created with Sketch. 4
    One concern i have following on from the recent statements made by management about the 3rd version of pericoach which makes previous versions look like a T-Model ford...

    Has anyone realized that the all important 'clinical trails' are being conducted using the inferior T-Model version and not the V3.... How will this effect the trail results (?) ... Why are they formulating clinical evidence using an inferior version (?) Make no mistake the clinical trials are the only thing that will save this company .... the only thing and we are relying on the T Model ford version....!
 
watchlist Created with Sketch. Add ALT (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.